Severe COVID lung damage: who gets scarring and why?
NCT ID NCT04987528
First seen Feb 02, 2026 · Last updated Apr 30, 2026 · Updated 13 times
Summary
This study looks at 200 people with severe COVID-19 who needed intensive care. The goal is to find out how many develop permanent lung scarring (pulmonary fibrosis), what factors increase that risk, and whether scarring affects survival or time on a breathing machine. Researchers will use CT scans and blood tests to detect fibrosis without invasive procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hopital Europeen Marseille
Marseille, 13003, France
Conditions
Explore the condition pages connected to this study.